Literature DB >> 10321728

HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin.

S Y Fuchs1, A Chen, Y Xiong, Z Q Pan, Z Ronai.   

Abstract

SCF E3 ubiquitin ligases mediate ubiquitination and proteasome-dependent degradation of phosphorylated substrates. We identified a human F-box/WD40 repeats protein (HOS), which is homologous to Slimb/h betaTrCP. Being a part of SCF complex with Skp1 and Cullin1, HOS specifically interacted with the phosphorylated IkappaB and beta-catenin, targeting these proteins for proteasome-dependent degradation in vivo. This targeting required Cullin1 as expression of a mutant Cullin1 abrogated the degradation of IkappaB and of beta-catenin. Mutant HOS which lacks the F-box blocked TNF alpha-induced degradation of IkappaB as well as GSK3beta-mediated degradation of beta-catenin. This mutant also inhibited NF-kappaB transactivation and increased the beta-catenin-dependent transcription activity of Tcf. These results demonstrate that SCF(HOS) E3 ubiquitin ligase regulate both NF-kappaB and beta-catenin signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321728     DOI: 10.1038/sj.onc.1202760

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  69 in total

1.  The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1.

Authors:  C M Pfleger; M W Kirschner
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

2.  ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase.

Authors:  I Lassot; E Ségéral; C Berlioz-Torrent; H Durand; L Groussin; T Hai; R Benarous; F Margottin-Goguet
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U.

Authors:  Matti Davis; Ada Hatzubai; Jens S Andersen; Etti Ben-Shushan; Gregory Zvi Fisher; Avraham Yaron; Asne Bauskin; Frank Mercurio; Matthias Mann; Yinon Ben-Neriah
Journal:  Genes Dev       Date:  2002-02-15       Impact factor: 11.361

4.  IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.

Authors:  Chris Albanese; Kongming Wu; Mark D'Amico; Christy Jarrett; David Joyce; Julian Hughes; James Hulit; Toshiyuki Sakamaki; Maofu Fu; Avri Ben-Ze'ev; Jacqueline F Bromberg; Carmela Lamberti; Udit Verma; Richard B Gaynor; Stephen W Byers; Richard G Pestell
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

Review 5.  Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination.

Authors:  Julia Shackelford; Joseph S Pagano
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 6.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

7.  Crumbs promotes expanded recognition and degradation by the SCF(Slimb/β-TrCP) ubiquitin ligase.

Authors:  Paulo Ribeiro; Maxine Holder; David Frith; Ambrosius P Snijders; Nicolas Tapon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Authors:  Ying Li; K G Kuresh Kumar; Weigang Tang; Vladimir S Spiegelman; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells.

Authors:  K G Suresh Kumar; Jianghuai Liu; Ying Li; Duonan Yu; Andrei Thomas-Tikhonenko; Meenhard Herlyn; Serge Y Fuchs
Journal:  Cancer Biol Ther       Date:  2007-06-13       Impact factor: 4.742

10.  c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/beta-catenin signaling through GSK3beta pathway.

Authors:  Dong Hu; Wenfeng Fang; Anjia Han; Lindsay Gallagher; Roger J Davis; Bin Xiong; Wancai Yang
Journal:  Carcinogenesis       Date:  2008-10-24       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.